131 related articles for article (PubMed ID: 11037347)
1. CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours.
Pelosi G; Fraggetta F; Sonzogni A; Fazio N; Cavallon A; Viale G
Virchows Arch; 2000 Sep; 437(3):270-4. PubMed ID: 11037347
[TBL] [Abstract][Full Text] [Related]
2. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.
Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G
J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
4. CD99 reactivity in mesenchymal chondrosarcoma.
Granter SR; Renshaw AA; Fletcher CD; Bhan AK; Rosenberg AE
Hum Pathol; 1996 Dec; 27(12):1273-6. PubMed ID: 8958297
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
[TBL] [Abstract][Full Text] [Related]
6. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry.
Collins BT; Cramer HM; Frain BE; Davis MM
Diagn Cytopathol; 1998 Nov; 19(5):382-4. PubMed ID: 9812236
[TBL] [Abstract][Full Text] [Related]
8. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
9. Peripheral primitive neuroectodermal tumor of the ovary confirmed by CD99 immunostaining, karyotypic analysis, and RT-PCR for EWS/FLI-1 chimeric mRNA.
Kawauchi S; Fukuda T; Miyamoto S; Yoshioka J; Shirahama S; Saito T; Tsukamoto N
Am J Surg Pathol; 1998 Nov; 22(11):1417-22. PubMed ID: 9808135
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p30/32 mic2.
Sexton CW; White WL
Am J Dermatopathol; 1996 Dec; 18(6):601-5. PubMed ID: 8989933
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of CD99 in stomach cancer.
Jung KC; Park WS; Bae YM; Hahn JH; Hahn K; Lee H; Lee HW; Koo HJ; Shin HJ; Shin HS; Park YE; Park SH
J Korean Med Sci; 2002 Aug; 17(4):483-9. PubMed ID: 12172043
[TBL] [Abstract][Full Text] [Related]
12. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
15. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.
Ambros IM; Ambros PF; Strehl S; Kovar H; Gadner H; Salzer-Kuntschik M
Cancer; 1991 Apr; 67(7):1886-93. PubMed ID: 1848471
[TBL] [Abstract][Full Text] [Related]
16. Extraskeletal Ewing's sarcoma of the nose.
Böör A; Jurkovic I; Friedmann I; Plank L; Kocan P
J Laryngol Otol; 2001 Jan; 115(1):74-6. PubMed ID: 11233634
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
18. MIC2 analysis in pediatric lymphomas and leukemias.
Riopel M; Dickman PS; Link MP; Perlman EJ
Hum Pathol; 1994 Apr; 25(4):396-9. PubMed ID: 8163272
[TBL] [Abstract][Full Text] [Related]
19. Synovial sarcoma, histologically mimicking primitive neuroectodermal tumor/Ewing's sarcoma at distant sites.
Masui F; Matsuno Y; Yokoyama R; Nakanishi Y; Hasegawa T; Kanai Y; Beppu Y; Hirohashi S; Fujii K; Shimoda T
Jpn J Clin Oncol; 1999 Sep; 29(9):438-41. PubMed ID: 10563198
[TBL] [Abstract][Full Text] [Related]
20. MIC2 analysis of small cell carcinoma.
Lumadue JA; Askin FB; Perlman EJ
Am J Clin Pathol; 1994 Nov; 102(5):692-4. PubMed ID: 7524308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
